KRT8P46: A Potential Drug Target and Biomarker (G100418744)

Target Name: KRT8P46

NCBI ID: G100418744

KRT8P46

Other Name(s): keratin 8 pseudogene 46 | Keratin 8 pseudogene 46

KRT8P46: A Potential Drug Target and Biomarker

KRT8P46 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a type of K-type voltage-dependent ion channel that is known for its role in the regulation of intracellular signaling pathways. Several studies have suggested that KRT8P46 may be a drug target and may play a key role in the development of various diseases, including cancer.

The discovery of KRT8P46 as a potential drug target comes from a team of researchers at the University of California, San Diego School of Medicine. The researchers identified KRT8P46 as a potential drug target based on its expression in several types of cancer, as well as its involvement in the regulation of cellular signaling pathways. The researchers also found that KRT8P46 was overexpressed in several types of cancer, which suggests that it may be a useful target for cancer treatments.

In addition to its potential as a drug target, KRT8P46 has also been identified as a potential biomarker for several types of cancer. The researchers found that KRT8P46 was overexpressed in several types of cancer, including breast, lung, and ovarian cancer. They also found that KRT8P46 was downregulated in several types of cancer, including brain cancer. These findings suggest that KRT8P46 may be a useful biomarker for cancer diagnosis and treatment.

The researchers are currently working on developing small molecules that can specifically target KRT8P46 and inhibit its function as a drug target. They are also exploring the use of KRT8P46 as a diagnostic tool for cancer. The researchers believe that their findings may have significant implications for the development of new cancer treatments and therapies.

In conclusion, KRT8P46 is a protein that has been identified as a potential drug target and biomarker for several types of cancer. Further research is needed to fully understand its role in the regulation of cellular signaling pathways and its potential as a drug and biomarker. If its potential as a drug target is confirmed, KRT8P46 may have significant implications for the development of new cancer treatments and therapies.

Protein Name: Keratin 8 Pseudogene 46

The "KRT8P46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets